arrow_back Back to App

November Designated American Diabetes Month: Boosting Awareness and Early Detection

The US Senate designated November 2024 as American Diabetes Month to raise awareness about this serious chronic condition affecting millions of Americans. The resolution aims to promote education, early detection, and support research into treatment and prevention. It highlights the significant health and financial burden of diabetes, including high costs and barriers to accessing necessary care like insulin.
Key points
Public Awareness Boost: Encouraging citizens to learn symptoms and risk factors for diabetes (e.g., age over 45, overweight, family history) to facilitate early detection.
Support for Research: Emphasizing the importance of research to reduce the prevalence of type 1, type 2, and gestational diabetes.
Addressing Healthcare Access: Recognizing the need to remove barriers that limit access to necessary healthcare resources for prevention and management of the condition.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 118_SRES_899
Sponsor: Sen. Shaheen, Jeanne [D-NH]
Process start date: 2024-11-19
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating November 2024 as "American Diabetes Month".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_SRES_899.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-11-19.

What are the main provisions?

Key points include:

  • Public Awareness Boost: Encouraging citizens to learn symptoms and risk factors for diabetes (e.g., age over 45, overweight, family history) to facilitate early detection.
  • Support for Research: Emphasizing the importance of research to reduce the prevalence of type 1, type 2, and gestational diabetes.
  • Addressing Healthcare Access: Recognizing the need to remove barriers that limit access to necessary healthcare resources for prevention and management of the condition.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Shaheen, Jeanne [D-NH].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6639-6640; text: CR S6637)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health